Posts Tagged: commercialization
Imagine a machine that makes layered, substantial patches of engineered tissue – tissue that could be used as grafts for burn victims or vascular patches. If this sounds like science fiction, researchers at the University of Toronto say it’s a…
With just a few words, Padina Pezeshki captivated her audience: “Here’s a woman suffering from advanced breast cancer,” she said simply, “the kind that has spread to her bones. The kind that has fractured her spine.” But Pezeshki, a PhD candidate at…
U of T spin-off company, Interface Biologics Inc. (IBI), founded by Professor Paul Santerre (Director, IBBME), continues to garner technical and commercial success. On December 6, IBI announced a $1-million investment by Ontario’s Investment Accelerator Fund – Life Sciences (IAF-LS). The IAF-LS…
Biomedical implants have the potential to transform everything – from drug delivery, to orthopedics and neurology. They’re crucial to new treatments that will help meet the challenges posed by an aging population – and transform the practice of medicine. There’s…
Making medical devices that address the challenge of delivering safe care to patients is standard procedure at the Institute of Biomaterials & Biomedical Engineering (IBBME). Just ask Professor Paul Santerre, IBBME Director, who developed Endexo Technology through his spin-off company, Interface…
It was an earth-moving idea that won recent Civil Engineering graduate Michael Montgomery (CivE, PhD 1T1) the NSERC Innovation Challenge Award. Or rather, it was the novel approach to keeping buildings structurally sound after the earth moves that was key. Montgomery, who…
Showing 97 - 102 of 107 results